Turnstone Biologics Operating Income

Turnstone Biologics (TSBX) currently reports a operating income of $-44M as of June 2025. That compares with $-80M in the prior-year period — up 44.1% year over year. Use the charts on this page to explore Turnstone Biologics's operating income history and peer comparisons.

Turnstone Biologics's operating income increased from $-80M to $-44M — a 44.1% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Turnstone Biologics reported $-44M in operating income as of June 2025. That compares with $-80M in the prior-year period — up 44.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-44M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Turnstone Biologics, and consider following TSBX for alerts when major investors trade the stock.